Welcome to our dedicated page for AlphaTON Capital SEC filings (Ticker: ATON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AlphaTON Capital Corp filings document the foreign private issuer's transition into Alpha Compute Corp, its amended memorandum and articles of association, and related Nasdaq symbol change disclosures. Form 6-K reports also cover material agreements, AI compute infrastructure leases, registration-statement incorporation by reference, shelf and at-the-market offering activity, and ordinary-share capital structure.
The filing record includes governance changes, board composition updates, shareholder voting and security-structure matters, Nasdaq listing compliance notices, rescission of a prior share-exchange transaction, operating and financial updates, and clinical or regulatory disclosures tied to the company's legacy immunotherapy business.
AlphaTON Capital Corp has received a notice from the Nasdaq Listing Qualifications Department stating that its common stock no longer meets the Nasdaq Capital Market’s minimum bid price requirement of $1.00 per share, after trading below this level for 30 consecutive business days.
The company has a 180-day compliance period, until August 31, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. If it qualifies, AlphaTON may receive an additional 180 days; otherwise, its shares could become subject to delisting, with the option to appeal to a Nasdaq Hearings Panel.
AlphaTON Capital Corp entered a binding call option agreement granting Immunova the right to acquire iOx Therapeutics, its wholly owned biotech subsidiary focused on liposomal iNKT agonists. If Immunova exercises the option and the acquisition closes, AlphaTON would receive an upfront cash payment, equity equal to 10% of the fully diluted acquiring entity, potential milestone payments that could exceed $100 million, and single-digit royalties on future net sales.
iOx’s lead drug candidate, PORT-2 (IMM60), has Phase 1/2 data in advanced melanoma and metastatic NSCLC showing it was well tolerated with biomarker evidence of immune activation and early signs of anti-tumor activity. Management frames the structure as a way to unlock value from this legacy biotech asset while retaining meaningful long-term economic participation, allowing AlphaTON to prioritize its Telegram-focused technology strategy and other biotech programs. The call option is subject to conditions, including Immunova securing financing, and there is no assurance it will be exercised or that the transaction will close.
AlphaTON Capital Corp entered a binding call option agreement granting Immunova the right to acquire iOx Therapeutics, its wholly owned biotech subsidiary focused on liposomal iNKT agonists. If Immunova exercises the option and the acquisition closes, AlphaTON would receive an upfront cash payment, equity equal to 10% of the fully diluted acquiring entity, potential milestone payments that could exceed $100 million, and single-digit royalties on future net sales.
iOx’s lead drug candidate, PORT-2 (IMM60), has Phase 1/2 data in advanced melanoma and metastatic NSCLC showing it was well tolerated with biomarker evidence of immune activation and early signs of anti-tumor activity. Management frames the structure as a way to unlock value from this legacy biotech asset while retaining meaningful long-term economic participation, allowing AlphaTON to prioritize its Telegram-focused technology strategy and other biotech programs. The call option is subject to conditions, including Immunova securing financing, and there is no assurance it will be exercised or that the transaction will close.
AlphaTON Capital Corp signed and closed a $30 million AI compute infrastructure lease to add 504 NVIDIA Blackwell B200 GPUs in Canada. The company expects this deployment to generate a minimum of $1.2 million in monthly revenue starting in March 2026 through hourly rentals to AI developers, enterprises, and the Telegram ecosystem.
At illustrative pricing of $4 per chip per hour, AlphaTON estimates about $1.45 million in monthly revenue from the 504 chips, and projects about $3.11 million per month once a total of 1,080 B200 and B300 chips are online by April 2026. Management cites a 1.7x return multiple and 40% IRR for this lease, positioning the deployment within a broader strategy to scale privacy-centric AI infrastructure for Telegram’s roughly 1 billion users.
AlphaTON Capital Corp signed and closed a $30 million AI compute infrastructure lease to add 504 NVIDIA Blackwell B200 GPUs in Canada. The company expects this deployment to generate a minimum of $1.2 million in monthly revenue starting in March 2026 through hourly rentals to AI developers, enterprises, and the Telegram ecosystem.
At illustrative pricing of $4 per chip per hour, AlphaTON estimates about $1.45 million in monthly revenue from the 504 chips, and projects about $3.11 million per month once a total of 1,080 B200 and B300 chips are online by April 2026. Management cites a 1.7x return multiple and 40% IRR for this lease, positioning the deployment within a broader strategy to scale privacy-centric AI infrastructure for Telegram’s roughly 1 billion users.
AlphaTON Capital Corp established an at-the-market share offering program allowing it to sell up to $400,000,000 of its ordinary shares through H.C. Wainwright & Co. as sales agent or principal. Sales will be made under an effective Form F-3 shelf and a new prospectus supplement, with commissions of up to 3.0% of gross proceeds.
The company plans to use any net proceeds to fund capital spending for development, training and operation of its Cocoon AI platform, including servers, GPUs and related infrastructure, to pursue complementary acquisitions or investments, and for working capital and other general corporate purposes.
AlphaTON Capital Corp established an at-the-market share offering program allowing it to sell up to $400,000,000 of its ordinary shares through H.C. Wainwright & Co. as sales agent or principal. Sales will be made under an effective Form F-3 shelf and a new prospectus supplement, with commissions of up to 3.0% of gross proceeds.
The company plans to use any net proceeds to fund capital spending for development, training and operation of its Cocoon AI platform, including servers, GPUs and related infrastructure, to pursue complementary acquisitions or investments, and for working capital and other general corporate purposes.
AlphaTON Capital Corp is launching an at-the-market equity program to sell up to $400,000,000 of ordinary shares through H.C. Wainwright as sales agent or principal. Shares may be sold from time to time on Nasdaq under the symbol ATON or through other permitted methods at prevailing market prices.
The company plans to use net proceeds mainly to fund capital expenditures for Cocoon AI, including servers, GPUs and related infrastructure, and to pursue strategic acquisitions or investments aligned with the Telegram and TON ecosystem, with any remainder for working capital and general corporate purposes.
As context, AlphaTON reports 23,434,588 ordinary shares outstanding as of February 13, 2026, so issuing a large portion of the program would significantly increase the share count and dilute existing holders. Wainwright will receive up to a 3.0% sales commission on gross proceeds.
AlphaTON Capital Corp is launching an at-the-market equity program to sell up to $400,000,000 of ordinary shares through H.C. Wainwright as sales agent or principal. Shares may be sold from time to time on Nasdaq under the symbol ATON or through other permitted methods at prevailing market prices.
The company plans to use net proceeds mainly to fund capital expenditures for Cocoon AI, including servers, GPUs and related infrastructure, and to pursue strategic acquisitions or investments aligned with the Telegram and TON ecosystem, with any remainder for working capital and general corporate purposes.
As context, AlphaTON reports 23,434,588 ordinary shares outstanding as of February 13, 2026, so issuing a large portion of the program would significantly increase the share count and dilute existing holders. Wainwright will receive up to a 3.0% sales commission on gross proceeds.
AlphaTON Capital Corp entered into a termination, rescission and transfer agreement with Compedica Holdings Limited to unwind a prior share-for-share exchange. The June 2025 deal had swapped 625,000 AlphaTON ordinary shares at $8.00 per share for 1,165,501 Compedica shares at $4.29 per share.
Under the new agreement, each party returned the shares it had received, with no additional consideration paid. The agreement includes customary representations, warranties, mutual indemnities and broad mutual releases of claims related to the original exchange.
AlphaTON Capital Corp entered into a termination, rescission and transfer agreement with Compedica Holdings Limited to unwind a prior share-for-share exchange. The June 2025 deal had swapped 625,000 AlphaTON ordinary shares at $8.00 per share for 1,165,501 Compedica shares at $4.29 per share.
Under the new agreement, each party returned the shares it had received, with no additional consideration paid. The agreement includes customary representations, warranties, mutual indemnities and broad mutual releases of claims related to the original exchange.
AlphaTON Capital Corp maintains its registration of 481,581 Ordinary Shares underlying warrants and issues a prospectus supplement that incorporates new corporate information. The supplement attaches a Form 6-K reporting that director Steven Mintz resigned effective February 6, 2026, and that F. Daniel Siciliano was unanimously appointed to the board the same day. The company notes its Ordinary Shares trade on Nasdaq under the symbol ATON, with a February 5, 2026 closing price of $0.4927.
AlphaTON Capital Corp reported changes to its board of directors. On February 5, 2026, Steven Mintz informed the company that he would resign from the board, effective February 6, 2026.
On February 6, 2026, F. Daniel Siciliano joined the board following a unanimous vote in favor by the existing directors, providing continuity in board governance following the resignation.
AlphaTON Capital Corp received an amended ownership report showing that Orca Capital, a Germany-based investor, beneficially owns 640,000 Ordinary Shares, equal to 4.5% of the class. Orca has sole power to vote and dispose of all these shares.
The percentage is calculated using 14,314,588 Ordinary Shares outstanding, reflecting AlphaTON’s registered offering described in a prospectus filed on January 15, 2026. Orca filed on a passive basis, certifying the shares were not acquired to change or influence control of the company.
AlphaTON Capital Corp is registering 481,581 Ordinary Shares underlying warrants through a supplemented prospectus. The supplement adds a Form 6-K that includes a press release describing net capital raises of $44 million, including a $15 million registered direct offering at $1.00 per share, mainly funding GPU infrastructure for Cocoon AI and working capital.
The company has initiated a $46 million investment for 576 NVIDIA B300 chips, targeting a projected 27% IRR, 282% ROI and $11 million Net Present Value, and exited SEC “baby-shelf” limits with a $420.69 million shelf registration. AlphaTON reports that its Cocoon AI network deployment began generating AI inference revenue in December and highlights new partnerships, including Midnight Foundation and data center operator atNorth AB, plus product launches such as the AlphaTON Claude Connector and the planned Alpha Liquid Terminal trading application.
AlphaTON Capital Corp is registering 481,581 Ordinary Shares underlying warrants through a supplemented prospectus. The supplement adds a Form 6-K that includes a press release describing net capital raises of $44 million, including a $15 million registered direct offering at $1.00 per share, mainly funding GPU infrastructure for Cocoon AI and working capital.
The company has initiated a $46 million investment for 576 NVIDIA B300 chips, targeting a projected 27% IRR, 282% ROI and $11 million Net Present Value, and exited SEC “baby-shelf” limits with a $420.69 million shelf registration. AlphaTON reports that its Cocoon AI network deployment began generating AI inference revenue in December and highlights new partnerships, including Midnight Foundation and data center operator atNorth AB, plus product launches such as the AlphaTON Claude Connector and the planned Alpha Liquid Terminal trading application.